Reuters logo
BRIEF-Cynata Therapeutics announces positive data from cyp mscs in 2nd preclinical asthma study
August 23, 2017 / 12:50 AM / a month ago

BRIEF-Cynata Therapeutics announces positive data from cyp mscs in 2nd preclinical asthma study

Aug 23 (Reuters) - Cynata Therapeutics Ltd

* Positive data from cyp mscs in 2nd preclinical asthma study Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below